ARCHIVES

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

This article is from The Cancer Letter archive.

Vol. 33 No. 08 | March 2, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Future Budget Planning Now In Open; One Or Two comp Centers In 12-18 Months

May 28, 1976

Switch T CD-Rom To Save PDQ $1 Mil. Over Five Years

September 14, 1990

Brigid Levental, Pediatric researcher, Dead At 58

February 18, 1994

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990

CCOP Applications Total 162; Three Committees, Headed By Ahmann, Loeb, Spur Will Review Them

November 19, 1982

Bonadonna, Fisher Share %50,000 Bristol-Myers Award

April 23, 1993